Label Changes for:

Lithobid (lithium carbonate) Extended-Release tablets

October 2011

Changes have been made to the WARNINGS and ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

 

WARNINGS

  • the unmasking of Brugada Syndrome [added]

 

ADVERSE REACTIONS

  • the unmasking of Brugada Syndrome [added]

 

PATIENT COUNSELING INFORMATION

  • the unmasking of Brugada Syndrome [added]
Hide
(web4)